BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23282142)

  • 1. Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening.
    Teo CY; Shave S; Chor AL; Salleh AB; Rahman MB; Walkinshaw MD; Tejo BA
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S4. PubMed ID: 23282142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential.
    Jones JE; Causey CP; Knuckley B; Slack-Noyes JL; Thompson PR
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):616-27. PubMed ID: 19736621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
    Knuckley B; Luo Y; Thompson PR
    Bioorg Med Chem; 2008 Jan; 16(2):739-45. PubMed ID: 17964793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new inhibitor for the protein arginine deiminase type 4 (PAD4) by rational design of α-enolase-derived peptides.
    Ahmad Nadzirin I; Chor ALT; Salleh AB; Rahman MBA; Tejo BA
    Comput Biol Chem; 2021 Jun; 92():107487. PubMed ID: 33957477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of natural inhibitors against peptidyl arginine deiminase 4 from herbal extracts by a high-performance liquid chromatography ultraviolet-visible based method.
    Zhao J; Li Y; Gao C; Zhao Z; Zhang S; Dong J; Zuo H; Chen X; Xie B; Guo Z; Wang Y; Li H; Bian Y
    J Chromatogr A; 2024 Feb; 1716():464643. PubMed ID: 38232639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
    Luo Y; Arita K; Bhatia M; Knuckley B; Lee YH; Stallcup MR; Sato M; Thompson PR
    Biochemistry; 2006 Oct; 45(39):11727-36. PubMed ID: 17002273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidylarginine deiminases 4 as a promising target in drug discovery.
    Yang C; Dong ZZ; Zhang J; Teng D; Luo X; Li D; Zhou Y
    Eur J Med Chem; 2021 Dec; 226():113840. PubMed ID: 34520958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis.
    Darrah E; Kim A; Zhang X; Boronina T; Cole RN; Fava A; Giles JT; Bingham III CO; Chalmers MJ; Griffin PR; Sadegh-Nasseri S; Rosen A
    J Proteome Res; 2017 Jan; 16(1):355-365. PubMed ID: 27700100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel furan-containing peptide-based inhibitors of protein arginine deiminase type IV (PAD4).
    Teo CY; Tejo BA; Leow ATC; Salleh AB; Abdul Rahman MB
    Chem Biol Drug Des; 2017 Dec; 90(6):1134-1146. PubMed ID: 28581157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
    Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
    Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.
    Koushik S; Joshi N; Nagaraju S; Mahmood S; Mudeenahally K; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
    Expert Opin Ther Targets; 2017 Apr; 21(4):433-447. PubMed ID: 28281906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors.
    Trabocchi A; Pala N; Krimmelbein I; Menchi G; Guarna A; Sechi M; Dreker T; Scozzafava A; Supuran CT; Carta F
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):466-71. PubMed ID: 25198885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
    Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.
    Gómez-Bañuelos E; Shi J; Wang H; Danila MI; Bridges SL; Giles JT; Sims GP; Andrade F; Darrah E
    Arthritis Rheumatol; 2022 Nov; 74(11):1746-1754. PubMed ID: 35675168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
    Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
    ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of p53 target gene expression by peptidylarginine deiminase 4.
    Li P; Yao H; Zhang Z; Li M; Luo Y; Thompson PR; Gilmour DS; Wang Y
    Mol Cell Biol; 2008 Aug; 28(15):4745-58. PubMed ID: 18505818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation.
    Knuckley B; Causey CP; Pellechia PJ; Cook PF; Thompson PR
    Chembiochem; 2010 Jan; 11(2):161-5. PubMed ID: 20014086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
    Bozdag M; Dreker T; Henry C; Tosco P; Vallaro M; Fruttero R; Scozzafava A; Carta F; Supuran CT
    Bioorg Med Chem Lett; 2013 Feb; 23(3):715-9. PubMed ID: 23265898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody discovery identifies regulatory mechanisms of protein arginine deiminase 4.
    Zhou X; Kong S; Maker A; Remesh SG; Leung KK; Verba KA; Wells JA
    Nat Chem Biol; 2024 Jun; 20(6):742-750. PubMed ID: 38308046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate.
    Pollmann S; Stensland M; Halvorsen EH; Sollid LM; Kvien TK; Fleckenstein B; Molberg O
    Rheumatol Int; 2012 May; 32(5):1271-6. PubMed ID: 21267570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.